Search Results
complexes in the lanthanide series. Experimental Preparation of Ln 2 (C 12 H 6 O 4 ) 3 · n H 2 O Due to insolubility of 2,3-naphthalenedicarboxylic acid in water, we prepared its ammonium salt (pH = 5.8) to
four new compound is successfully ended. Finally elemental analysis confirms these four structures: compound 1 Anal. Calcd for C 21 H 24 N 4 O 3 : C, 66.30; H, 6.36; N, 14.73. Found: C, 66.39; H, 6.33; N, 14.37, compound 2 : Anal. Calcd for C
-hydroxyflavonone 1 , C 15 H 10 O 4 , 1 H NMR (500 MHz, CD 3 OD) δ 7.73 (1H, d, J = 8.7 Hz, H-4), 7.49 (2H, d, J = 7.5 Hz, H-2′,6′), 7.40 (2H, t, J = 7.5 Hz, H-3′, 5′), 7.35 (1H, d, J = 7.5 Hz, H-4′), 6.51 (1H, dd, J = 8.7,1.6 Hz, H-6), 6.39 (1H, d, J
) with their peak at m/e 511. The species (c) further degrades with the subsequent loss of –C 4 H 3 species forming species (d) with their peak at m/e 460. The species (d) further degrades with the subsequent loss of –C 3 H 6 species forming species
O (18 Da) between the 2″-hydroxyl group of the sugar and the 5 or 7-hydroxyl group of the aglycone. The fragment ions at m / z 357.0694 ( 0,3 X 0 − ), m / z 327.0585 ( 0,2 X 0 − ), and m / z 297.0468 ( 0,1 X 0 − ) indicate the losses of C 3 H 6
.7 Hz); H 5 = 6.78 (s, 2H); H 6 = 3.76 (t, 2H, J = 4.9 Hz); H 7 = 3.75 (t, 2H, J = 6.3 Hz); H 8 = 3.44 (s, 4H); H 9 = 3.33 (s, 4H); H 10 = 3.21 (t, 2H, J = 5.3 Hz); H 11 = 3.17 (t, 2H, J = 7.7 Hz); H 12 = 1.83 (q, 2H, J = 7.7 Hz). 13 C
.5%), trans -aconitic acid, C 6 H 6 O 6 , (≥98%) and cis -aconitic acid, C 6 H 6 O 6 , (≥98%) were purchased from Aldrich Chemical Corp. and were used without further purification. Methods The TG-FTIR analyses in argon (Ar
oral alectinib capsules twice daily (Alecensa®, 600 mg). Lithium heparin blood samples (1–2 mL) were collected prior to the first alectinib dose, then at 0 min, 0.5 h, 1 h, 2 h, 4 h, 6 h, 12 h, and 24 h after the first dose, and then immediately prior
SBA-15 silicas containing sucrose
Chemical, structural, and thermal studies
. Trewyn , BG , Giri , S , Slowing , II , Lin , VSY 2007 Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor system . Chem Commun 44 : 3236 – 3244 10.1039/b701744h . 6
O 3 130.0497 108.0807 91.0542 60.0451 C 5 H 8 NO 3 C 7 H 10 N C 7 H 7 C 2 H 6 NO X X 5 M4 2
